Nuclear Medicine and Biology
Volume 33, Issue 5 , Pages 615-624 , July 2006

Synthesis and biological evaluation of a fluorine-18-labeled nonsteroidal androgen receptor antagonist, N-(3-[18F]fluoro-4-nitronaphthyl)-cis-5-norbornene-endo-2,3-dicarboxylic imide

  • Ephraim E. Parent

      Affiliations

    • Department of Chemistry, University of Illinois, Urbana, IL 61801, USA
    • ,
  • Carmen S. Dence

      Affiliations

    • Washington University School of Medicine, St. Louis, MO 63110, USA
    • ,
  • Terry L. Sharp

      Affiliations

    • Washington University School of Medicine, St. Louis, MO 63110, USA
    • ,
  • Michael J. Welch

      Affiliations

    • Washington University School of Medicine, St. Louis, MO 63110, USA
    • ,
  • John A. Katzenellenbogen

      Affiliations

    • Department of Chemistry, University of Illinois, Urbana, IL 61801, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 217 333 6310.

Received 20 March 2006 ,Revised 5 April 2006 ,Accepted 15 April 2006.

References 

  1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun Michael J. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5–26
  2. Huggins C. Endocrine-induced regression of cancers. Cancer Res. 1967;27:1925–1930
  3. Scher HI, Liebertz C, Kelly WK, Mazumdar M, Brett C, Schwartz L, et al. Bicalutamide for advanced prostate cancer: the natural versus treated history of disease. J Clin Oncol. 1997;15:2928–2938
  4. Welch MJ. New approaches to imaging and therapy of cancer. In: Abstracts of papers, 223rd ACS National Meeting, Orlando, FL, USA, April 7–11, 2002, NUCL-035. 2002;
  5. Liu A, Carlson KE, Katzenellenbogen JA. Synthesis of high-affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography. J Med Chem. 1992;35:2113–2129
  6. Choe YS, Lidstrom PJ, Chi DY, Bonasera TA, Welch MJ, Katzenellenbogen JA. Synthesis of 11 β-[18F]fluoro-5 alpha-dihydrotestosterone and 11 β-[18F]fluoro-19-nor-5 α-dihydrotestosterone: preparation via halofluorination–reduction, receptor binding, and tissue distribution. J Med Chem. 1995;38:816–825
  7. Liu A, Dence CS, Welch MJ, Katzenellenbogen JA. Fluorine-18-labeled androgens: radiochemical synthesis and tissue distribution studies on six fluorine-substituted androgens, potential imaging agents for prostatic cancer. J Nucl Med. 1992;33:724–734
  8. Ali H, Rousseau J, Ahmed N, Guertin V, Hochberg RB, van Lier JE. Synthesis of the 7α-cyano-(17α,20E/Z)-[125I]iodovinyl-19-nortestosterones: potential radioligands for androgen and progesterone receptors. Steroids. 2003;68:1163–1171
  9. Garg PK, Labaree DC, Hoyte RM, Hochberg RB. [7α-18F]fluoro-17α-methyl-5α-dihydrotestosterone: a ligand for androgen receptor-mediated imaging of prostate cancer. Nucl Med Biol. 2001;28:85–90
  10. Dehdashti F, Picus J, Michalski Jeff M, Dence Carmen S, Siegel Barry A, Katzenellenbogen John A, et al. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur J Nucl Med Mol Imaging. 2005;32:344–350
  11. Zanzonico PB, Finn R, Pentlow KS, Erdi Y, Beattie B, Akhurst T, et al. PET-based radiation dosimetry in man of 18-F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer. J Nucl Med. 2004;45:1966–1971
  12. Larson SM, Morris M, Gunther I, Beattie B, Humm JL, Akhurst TA, et al. Tumor localization of 16β-18F-fluoro-5α-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer. J Nucl Med. 2004;45:366–373
  13. Liu A, Katzenellenbogen JA, VanBrocklin HF, Mathias CJ, Welch MJ. 20-[18F]fluoromibolerone, a positron-emitting radiotracer for androgen receptors: synthesis and tissue distribution studies. J Nucl Med. 1991;32:81–88
  14. Asade RH, Prizont L, Muino JP, Tessler J. Steady-state hydroxyflutamide plasma levels after the administration of two dosage forms of flutamide. Cancer Chemother Pharmacol. 1991;27:401–405
  15. Schulz M, Schmoldt A, Donn F, Becker H. The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment. Eur J Clin Pharmacol. 1988;34:633–636
  16. Zhi L, Martinborough E. Selective androgen receptor modulators (SARMs). Annu Rep Med Chem. 2001;36:169–180
  17. Dalton JT, Mukherjee A, Zhu Z, Kirkovsky L, Miller DD. Discovery of nonsteroidal androgens. Biochem Biophys Res Commun. 1998;244:1–4
  18. Tucker H, Crook JW, Chesterson GJ. Nonsteroidal antiandrogens. Synthesis and structure–activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides. J Med Chem. 1988;31:954–959
  19. Jacobson O, Bechor Y, Icar A, Novak N, Birman A, Marom H, et al. Prostate cancer PET bioprobes: synthesis of [18F]-radiolabeled hydroxyflutamide derivatives. Bioorg Med Chem. 2005;13:6195–6205
  20. Salvati ME, Balog A, Shan W, Wei DD, Pickering D, Attar RM, et al. Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists. Bioorg Med Chem Lett. 2005;15:271–276
  21. Salvati ME, Balog A, Wei DD, Pickering D, Attar RM, Geng J, et al. Identification of a novel class of androgen receptor antagonists based on the bicyclic-1H-isoindole-1,3(2H)-dione nucleus. Bioorg Med Chem Lett. 2005;15:389–393
  22. Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GGJM, Jenster G, Trapman J, et al. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol. 1992;41:665–669
  23. Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, et al. Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res. 1997;3:2493–2500
  24. Zhao X-Y, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, et al. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med (New York). 2000;6:703–706
  25. Balog A, Salvati ME, Shan W, Mathur A, Leith LW, Wei DD, et al. The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists. Bioorg Med Chem Lett. 2004;14:6107–6111
  26. Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, et al. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci U S A. 2001;98:4904–4909
  27. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, et al. Pyrazole ligands: structure–affinity/activity relationships and estrogen receptor-α-selective agonists. J Med Chem. 2000;43:4934–4947
  28. Makosza M-L, Bia-lecki M. Nitroarylamines via the vicarious nucleophilic substitution of hydrogen: amination, alkylamination, and arylamination of nitroarenes with sulfenamides. J Org Chem. 1998;63:4878–4888
  29. Pangborn AB, Giardello MA, Grubbs RH, Rosen RK, Timmers FJ. Safe and convenient procedure for solvent purification. Organometallics. 1996;15:1518–1520
  30. Still WC, Kahn M, Mitra A. Rapid chromatographic technique for preparative separations with moderate resolution. J Org Chem. 1978;43:2923–2925
  31. Brandes SJ, Katzenellenbogen JA. Fluorinated androgens and progestins: molecular probes for androgen and progesterone receptors with potential use in positron emission tomography. Mol Pharmacol. 1987;32:391–403
  32. Vijaykumar D, Al-Qahtani MH, Welch MJ, Katzenellenbogen JA. Synthesis and biological evaluation of a fluorine-18 labeled estrogen receptor-α selective ligand: [18F] propyl pyrazole triol. Nucl Med Biol. 2003;30:397–404
  33. Sharp TL, Dence CS, Engelbach JA, Herrero P, Gropler RJ, Welch MJ. Techniques necessary for multiple tracer quantitative small-animal imaging studies. Nucl Med Biol. 2005;32:875–884
  34. Hashimoto A, Przybyl AK, Linders JTM, Kodato S, Tian X, Deschamps JR, et al. Probes for narcotic receptor-mediated phenomena: 33. Construction of a strained trans-5,6-ring system by displacement of a nitro-activated aromatic fluorine. Synthesis of the penultimate oxide-bridged phenylmorphans. J Org Chem. 2004;69:5322–5327
  35. Vlasov VM. Nucleophilic substitution of the nitro group, fluorine and chlorine in aromatic compounds. Russ Chem Rev. 2003;72:681–703
  36. Cervera M, Marquet J, Martin X. Charge control in the SNAr reaction. Meta substitution with respect to the activating nitro group in 3,4-dihalogenonitrobenzenes. Tetrahedron. 1996;52:2557–2564
  37. Buncel E, Dust JM, Terrier F. Rationalizing the regioselectivity in polynitroarene anionic S-adduct formation. Relevance to nucleophilic aromatic substitution. Chem Rev (Washington, DC). 1995;95:2261–2280
  38. Esser F, Pook KH. Cyclic guanidines: IV. Intramolecular nucleophilic aromatic substitution of hydrogen in (3-nitrophenyl)guanidines. Synthesis. 1992;596–601
  39. Stern MK, Cheng BK. Amination of nitrobenzene via nucleophilic aromatic substitution for hydrogen: direct formation of aromatic amide bonds. J Org Chem. 1993;58:6883–6888
  40. Stern MK, Cheng BK, Hileman FD, Allman JM. A new route to 4-aminodiphenylamine via nucleophilic aromatic substitution for hydrogen: reaction of aniline and azobenzene. J Org Chem. 1994;59:5627–5632
  41. Coates WJ, McKillop A. Preparation of 4-amino-3(2H)-pyridazinones by direct amination of 3(2H)-pyridazinones with hydrazine. Heterocycles. 1989;29:1077–1090
  42. Smith GEP, Alliger G, Carr EL, Young KC. Thiocarbamylsulfenamides. J Org Chem. 1949;14:935–945
  43. Carr EL, Smith GEP, Alliger G. Thiazolesulfenamides. J Org Chem. 1949;14:921–934
  44. Maertens F, Toppet S, Hoornaert GJ, Compernolle F. Incorporation of an indole-containing diarylbutylamine pharmacophore into furo[2,3-a]carbazole ring systems. Tetrahedron. 2005;61:1715–1722
  45. Yonemoto K, Shibuya I, Honda K. Formation of 1,4,2,5-dithiadiazines as a heterocyclic system by reaction of 1,4,2-dithiazolium salts with sulfenamides. Bull Chem Soc Jpn. 1988;61:2232–2234
  46. Yin D, Zhang L, Tang G, Tang X, Wang Y. Enantioselective synthesis of no-carrier added (NCA) 6-[18F]fluoro-l-DOPA. J Radioanal Nucl Chem. 2003;257:179–185
  47. Blakey SB, MacMillan DWC. The first Suzuki Cross-couplings of aryltrimethylammonium salts. J Am Chem Soc. 2003;125:6046–6047
  48. Zhang L, Tang G, Yin D, Tang X, Wang Y. Enantioselective synthesis of no-carrier-added (NCA) 6-[18F]fluoro-l-DOPA. Appl Radiat Isot. 2002;57:145–151
  49. Getvoldsen G, Fredriksson A, Elander N, Stone-Elander S. Microwave-assisted cyclocondensation of 1,2-diaminobenzene with [4-18F]fluorobenzoic acid: microwave synthesis of 2-([4-18F]fluorophenyl)benzimidazole. J Labelled Compd Radiopharm. 2004;47:139–145
  50. Khan N-UH, Lee BC, Lee S-Y, Choe YS, Jun C-H, Chi DY. Hydroacylation by 4-[18F]fluorobenzaldehyde: a novel method for the preparation of 4-[18F]phenyl ketones. J Labelled Compd Radiopharm. 2002;45:1045–1053
  51. Pankratov AN. Electrophilic aromatic substitution regioselectivity for benzene derivatives in terms of cationic localization energies from semiempirical quantum chemical computations. Theochem. 2000;507:239–244
  52. Tadros W, Kamel M. Quaternary ammonium salts: II. A novel feature associated with decomposition of some quaternary ammonium salts. J Chem Soc, Abstr. 1951;1890–1892
  53. Zaki A, Fahim H. Some quaternary ammonium salts and their decomposition products. J Chem Soc, Abstr. 1942;270–272
  54. Hoyte RM, Borderon K, Bryson K, Allen R, Hochberg RB, Brown TJ. Synthesis and evaluation of 7α-iodo-5α-dihydrotestosterone as a potential radioligand for androgen receptor. J Med Chem. 1994;37:1224–1230
  55. Kilbourn MR, Jerabek PA, Welch MJ. An improved [18O]water target for [18F]fluoride production. Int J Appl Radiat Isot. 1985;36:327–328
  56. Grillo MP, Benet LZ. Studies on the reactivity of clofibryl-S-acyl-CoA thioester with glutathione in vitro. Drug Metab Dispos. 2002;30:55–62
  57. Grillo MP, Knutson CG, Sanders PE, Waldon DJ, Hua F, Ware JA. Studies on the chemical reactivity of diclofenac acyl glucuronide with glutathione: identification of diclofenac-S-acyl-glutathione in rat bile. Drug Metab Dispos. 2003;31:1327–1336
  58. Chesis PL, Griffeth LK, Mathias CJ, Welch MJ. Sex-dependent differences in N-(3-[18F]fluoropropyl)-N-nordiprenorphine biodistribution and metabolism. J Nucl Med. 1990;31:192–201
  59. Carlson KE, Katzenellenbogen JA. A comparative study of the selectivity and efficiency of target tissue uptake of five tritium-labeled androgens in the rat. J Steroid Biochem. 1990;36:549–561

PII: S0969-8051(06)00069-2

doi: 10.1016/j.nucmedbio.2006.04.003

Nuclear Medicine and Biology
Volume 33, Issue 5 , Pages 615-624 , July 2006

Article Tools

* Image Usage & Resolution